
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Click the title above to open the Applied Clinical Trials September/October 2017 issue in an interactive PDF format.
about 9 years ago
Europe’s Battle to Host EMA Post-Brexit Intensifiesabout 9 years ago
The Shifting Perspectives on Pharmacovigilance in Europeabout 9 years ago
The Emergence of the Patient-Centric Supply Chainabout 9 years ago
Enabling Healthcare Providers as Facilitators of Patient Engagementabout 9 years ago
Overcoming Complexities of Clinical Trial Supplies in Latin Americaabout 9 years ago
The Success of Cell Therapies Will Depend on Automationabout 9 years ago
Monitoring Temperature Control Throughout IMP Supply Journeyabout 9 years ago
Mitigating Supply Chain Risk in Clinical Trials





